Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
US-12509687-B2 · Dec 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Shuldiner Alan patents
Shuldiner Alan is listed as an inventor on 34 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shuldiner Alan |
| Total patents | 34 |
| First publication | Aug 10, 2017 |
| Latest publication | Dec 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
B4GALT1 variants and uses thereof
US-12480103-B2 · Nov 25, 2025 · US
17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025333737-A1 · Oct 30, 2025 · US
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-12359201-B2 · Jul 15, 2025 · US
Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Agonists
US-2024207204-A1 · Jun 27, 2024 · US
Hsd17b13 variants and uses thereof
US-2024141305-A1 · May 2, 2024 · US
Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors
US-2024076674-A1 · Mar 7, 2024 · US
HSD17B13 variants and uses thereof
US-11845963-B2 · Dec 19, 2023 · US
HSD17B13 variants and uses thereof
US-11753628-B2 · Sep 12, 2023 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors
US-2023263821-A1 · Aug 24, 2023 · US
Recent patents
Latest publications not already listed above.
Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
US-11713461-B2 · Aug 1, 2023 · US
Hsd17b13 variants and uses thereof
US-2023031669-A1 · Feb 2, 2023 · US
Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents
US-2023000897-A1 · Jan 5, 2023 · US
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
US-11504390-B2 · Nov 22, 2022 · US
HSD17B13 variants and uses thereof
US-11485958-B2 · Nov 1, 2022 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors
US-2022323483-A1 · Oct 13, 2022 · US
HSD17B13 Variants And Uses Thereof
US-2022267743-A1 · Aug 25, 2022 · US
Rodent Model Of Increased Bone Mineral Density
US-2022217956-A1 · Jul 14, 2022 · US
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
US-11331332-B2 · May 17, 2022 · US
17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
US-2021380985-A1 · Dec 9, 2021 · US
17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-11180757-B1 · Nov 23, 2021 · US
A rodent model of b4galt1-mediated functions
US-2021274759-A1 · Sep 9, 2021 · US
Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors
US-2021002647-A1 · Jan 7, 2021 · US
B4GALT1 Variants And Uses Thereof
US-2020399617-A1 · Dec 24, 2020 · US
Hsd17b13 variants and uses thereof
US-2020354693-A1 · Nov 12, 2020 · US
HSD17B13 variants and uses thereof
US-10787647-B2 · Sep 29, 2020 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors
US-2020297753-A1 · Sep 24, 2020 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors
US-2020297752-A1 · Sep 24, 2020 · US
B4GALT1 cDNA variants and compositions comprising the same
US-10738284-B2 · Aug 11, 2020 · US
Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
US-10463716-B2 · Nov 5, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 32 |
| Univ Maryland | 16 |
| Regeneran Pharmaceuticals Inc | 1 |
| Center For Non Communicable Diseases | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/20 | 22 |
| C12N15/113 | 21 |
| C12Q1/6883 | 21 |
| C12N2310/14 | 21 |
| C12Q2600/156 | 21 |